Upward socioeconomic mobility reduces dementia risk, study finds

FHS
May 27, 2024
12:57 am

Researchers found that upward socioeconomic status transitions throughout life reduce the risk of dementia and increase dementia-free periods, while downward transitions increase dementia risk.

Over 50% of U.S. Adults Qualify for Ozempic, Wegovy

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated. Among 25,531 participants in the National Health

November 19, 2024

Study explores adverse effects associated with psychotherapy

Psychotherapy is a key evidence-based method of treatment and rehabilitation for various mental health disorders, in addition to pharmacotherapy.

February 9, 2024

Tenpoint Therapeutics launches with $70M to restore vision with stem cell therapies and ‘reprogramming’ medicines

Although numerous biotech companies are developing gene therapies to correct eyesight, these approaches largely require the affected cells to remain intact — while many forms

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.